Inscrivez vous à la 4ème édition du congrès Immunotherapies & Innovations for Infectious Diseases! Les 9 et 10 décembre 2020. Cette année la conférence sera donné uniquement à distance et...
PRE-PRINT COVID19 : Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 in vitro infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19 Authors:...
Bioaster vient de publier les génomes bactériens de son modèle de souris gnotobiotique (GM15), mis au point pour produire un nouveau modèle standardisé de souris avec un microbiote intestinal contrôlé...
This #Multiomics study, combining #Metabolomics and #Transcriptomics, aims at deciphering the pathways involved in the immune response induced by an immune-stimulant in chickens. This work is part of a collaboration...
“Caecal microbiota compositions from 7-day-old chicks reared in high-performance and low-performance industrial farms and systematic culturomics to select strains with anti-Campylobacter activity”. Voir l’article. Ce travail mené en collaboration avec...
Through this collaboration, BIOASTER and MaaT Pharma illustrate once again the dynamism and quality of the French ecosystem in the promising field of microbiome, as well as the success of...
A partir d’aujourd’hui, nos activités courantes en cours au sein de l’Institut ont été encore réduites, voire même totalement stoppées pour certaines : pour faciliter le travail des hôpitaux et centre...
Nous traversons une crise majeure et inédite qui implique de repenser drastiquement nos modes de vie et de travail pour ralentir l’épidémie qui est désormais omniprésente, permettre à notre système...
Les technologies omiques sont aujourd’hui au cœur de la recherche fondamentale dans les domaines de la microbiologie et des maladies infectieuses. Pour implémenter ces technologies en recherche appliquée, nous devons...
N’oubliez pas de vous inscrire au prochain congrès I4ID 2019! Les inscriptions pour la 3ème édition du programme Immunothérapies et Innovation pour les maladies infectieuses (I4ID2019) sont toujours ouvertes. Le...
By continuing browsing this website, you accept the use of cookies or other tracers for statistics of visits to optimize the functionality of the site, and or privacy policy. AcceptRejectRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
